Recent News

and/or

66 News Items found

In the Lab

Researchers Identify Why Women May Develop Resistance to a New Class of Breast Cancer Drugs

Clues emerge about why promising new breast cancer drugs sometimes don’t work — and what might be done about it.

Image of dividing breast cancer cells taken with electron microscope.

Roundup

Advances in Myeloma, Lymphoma, and Bone Marrow Transplant Announced at the 2018 ASH Meeting

Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology.

ASH meeting signage

In the Clinic

Liquid Biopsy Is Effective at Guiding Treatment of Lung Cancer, Study Finds

The initial results of an ongoing study show that a liquid biopsy has advantages over a tissue biopsy for people with lung cancer.

A tube of blood superimposed on a lung and a DNA helix

Finding

Adding Low-Dose Radiation Could Make CAR T Therapy More Effective, Study Finds

The treatment combination appears to boost chimeric antigen receptor (CAR) T cells’ ability to kill cancer cells in solid tumors.

Blue cancer cell with a target on it

In the News

Former MSK Immunologist James Allison Wins Nobel Prize in Medicine

Dr. Allison is being honored for discovering how to take the brakes off cancer-fighting immune cells.

James Allison

Feature

Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy

An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.

MSK cell manufacturing specialist Xiuyan Wang

Feature

What Is Epigenetics, and Why Is Everyone Talking about It?

Epigenetics is frequently in the news, but there's lots of confusion about just what it entails.

A calico cat

Finding

Discovery of Unusual Cell Type Could Help Guide Immunotherapy

A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.

Scanning electron micrograph (SEM) of T lymphocyte cells (blue) attached to a red cancer cell.

In the Lab

Scientists Pinpoint a New Cause of Resistance to EGFR-Targeting Drugs

Multiple copies of a gene called YES1 appear to be responsible for certain precision drugs losing their effectiveness.

Blue cells containing small red and green dots on a black background